Quantessence Capital LLC Oric Pharmaceuticals, Inc. Transaction History
Quantessence Capital LLC
- $340 Billion
- Q2 2025
A detailed history of Quantessence Capital LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 11,868 shares of ORIC stock, worth $151,317. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,868Holding current value
$151,317% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
151Shares Held
97MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$91.3 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$84.1 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$83.8 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$67.4 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$61.6 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $505M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...